
Formation Biorevenue, valuation & funding
Pharma and Biotech SoftwareNew YorkFounded 2013CEO Benjamine Liu
Formation Bio is a tech-driven, AI-native pharma company changing the way drug development is done, focusing on more efficient drug selection and advancing drug assets through critical development milestones.
Formation Bio revenue
Formation Bio has not published its revenue. Growjo puts it at about $39.2M a year (September 2025).
| As of | Revenue | Source |
|---|---|---|
| Sep 2025 | $39.2MEST | Growjo estimate |
Formation Bio valuation
Formation Bio is privately held, so there is no Formation Bio stock to buy. Investors valued it at $1.7B in October 2025.
Valuation history$1.7B Valuation 2025$1B Series D 2024
Formation Bio funding rounds & investors
Formation Bio has raised $608M across three rounds since 2018. The latest was a $372M Series D in June 2024.
| Date | Round | Raised | Valuation | Source |
|---|---|---|---|---|
| Jun 2024 | Series D | $372M | $1B | PR Newswire |
| Sep 2021 | Series C | $156M | – | Reuters |
| 2018 | Series B | $80M | – | texau.com |
| Total raised | $608M |
Formation Bio CEO, founders & employees
Benjamine Liu founded Formation Bio in 2013 and runs it as CEO. Formation Bio has 188 employees (November 2025, LinkedIn).
- Benjamine LiuFounder & CEO
All 2 headcount readings, with sources
| As of | Employees | Source |
|---|---|---|
| Nov 2025 | 188 | |
| Sep 2025 | 179 |
Formation Bio FAQ
What is Formation Bio's revenue?
Growjo estimates Formation Bio's revenue at about $39.2M a year (September 2025). The company hasn't published its own figure.
What is Formation Bio's valuation?
Investors valued Formation Bio at $1.7B in October 2025.
How much funding has Formation Bio raised?
Formation Bio has raised $608M across three funding rounds. The latest was a $372M Series D in June 2024.
Is Formation Bio publicly traded?
No. Formation Bio is a private company, so its shares aren't traded on a stock exchange.
How many employees does Formation Bio have?
Formation Bio has 188 employees as of November 2025, according to LinkedIn.
Who is the CEO of Formation Bio?
Benjamine Liu is the CEO of Formation Bio and founded the company in 2013.
Who founded Formation Bio?
Benjamine Liu founded Formation Bio in 2013.
Browse Pharma and Biotech Software
- Chemify Limited$39.5M
- ArteraAI$34.3M
- Blue Mountain$24M
- Apprentice$55.2M
- Elucidata Corporation$22.2M
- ValGenesis$22M
- OPTIC$19.9M
- BrightInsight$19.4M
- SoftGroup$18.5M
- Aissel Technologies$17.3M
- Innoplexus$62M
- Genesis Molecular AI$16.1M
- IntegriChain$62.4M
- Within3$15M
- Aizon$14.6M
- Teckro$14.2M
- Float Health$11.7M
- Caliber$11M
- insitro$69M
- TileDB$8.8M
How this page is sourced
5 from public sources · 1 estimate. Founder figures link to the second they were said; public figures name their source; estimates are marked EST and say whose they are. Not financial advice.
Updated Oct 8, 2026Data disclaimerReport a correctionClaim this profileRun Formation Bio? Join the podcast